Accordingly, we used cfDNA to detect the levels of CD147 methylation in NSCLC patients and found that the CD147 methylation levels exhibited an inverse relationship with tumor size, lymphatic metastasis, and TNM stage. This evidence concerns the gene BSG and neoplasm.